Robinson James George 4/A
4/A · NYMOX PHARMACEUTICAL CORP · Filed Jun 26, 2023
Insider Transaction Report
Form 4/AAmended
Robinson James George
Director
Transactions
- Purchase
Common Stock
2023-04-27$0.47/sh+40,000$18,800→ 4,782,065 total - Purchase
Common Stock
2023-04-25$0.45/sh+40,000$18,000→ 4,742,065 total